GAIT 2010
Congress Information
Scientific Information
Sponsorship and Exhibition
Previous Congress
Gait & Movement Disorders Congress 2010, Washington D.C.

Invited Speakers 

Steve Agritelley, USA
John Argue, USA
David Bennet, USA
Bastiaan Bloem, The Netherlands
Nico Bohnen, USA
Michelle Carlson, USA
Carl W. Cotman, USA
Nir Giladi, Israel
Mark Hallet, USA
Janet Hamburg, USA
Jeffrey Hausdorff, Israel
Roee Holtzer, USA
Fay Horak, USA
Jeffrey Kaye, USA
Arthur Kramer, USA
Sallie Lamb, UK
Anthony Lang, Canada

Stephen Lord, Australia
Lillemor Lundin-Olsson, Sweden
Richard Macko, USA
Jane Mahoney, USA
Rolf Moe-Nilssen, Norway
John Nutt, USA
Alice Nieuwboer, Belgium
Mark Redfern, USA
Stephen Reich, USA
Stephen Robinovitch, Canada
Caterina Rosano, USA
Glenn Smith, USA
Stephanie Studenski, USA
Chris Todd, UK
Ergun Uc, USA 
Joseph Verghese, USA 

Speaker Biographies

S. Agritelley, USA

Steve Agritelley is the Director of Product Research and Innovation for Intel’s Digital Health Group. He is responsible for driving healthcare research worldwide and new product innovation.  The Digital Health Group co-founded some of the world’s largest research organizations devoted to advancing the cause of independent living, including the Technology Research for Independent Living (TRIL) Centre, and the Oregon Center for Aging & Technology (ORCATECH).  TRIL is a $30 million collaboration co-funded by Intel and the IDA Ireland and involves researchers from Intel, Trinity College Dublin, University College Dublin and the National University of Ireland Galway.  TRIL is an Ireland-based world class research center discovering and delivering technology solutions supporting independent living.   ORCATECH is funded by a prestigious Roybal Center Grant from the National Institute on Aging.  ORCATECH fosters translational research by exploring state of the art aging-in-place technologies through a community-based Living Laboratory. Steve joined Intel in 1995 and has held a variety of positions including IT architecture and engineering, management of distributed and mobile computing initiatives, operations management for a globally distributed systems software lab, and management of an interdisciplinary team of social science, hardware, software, and interaction design researchers. He holds a degree in Computer Science from Stanford University.

John Argue is an actor, director, and theater arts teacher who has lived and worked in the San Francisco Bay Area since 1960. He has taught drama, movement, and voice at the University of California at Berkeley, San Francisco State University, and the American Conservatory Theater. In 1970 he founded his own theater studio, where he produced original plays and pioneered advanced techniques for actor training. He has also worked as a drama therapist with children and adults.

Since 1985, Mr. Argue has been teaching movement and voice for people with Parkinson’s disease. His approach reflects his extensive training in yoga, tai chi, dance, and drama. Techniques of The John Argue Method™ are presented in the book Parkinson’s Disease and The Art of Moving and its Video Companion in VHS or DVD. The book has sold more than 30,000 copies, the video more than 3,000.

Mr. Argue is a frequent speaker at symposia and conferences for healthcare professionals, fitness and exercise teachers, and individuals and families whose lives are affected by Parkinson’s disease. He has been invited to 32 cities nationwide.

David A. Bennett, MD, is the Robert C. Borwell Professor of Neurological Sciences and director of the Rush Alzheimer's Disease Center. Dr. Bennett received the degree of bachelor of science with high distinction and high honors in physiology from the University of Michigan, Ann Arbor, in 1979. He earned his doctorate in medicine from Rush Medical College in 1984. Following his medical internship, Dr. Bennett returned to Rush for residency training in neurology and a research fellowship in dementia. Internationally known for his research regarding the causes, treatment and prevention of Alzheimer's disease and other common neurologic conditions of aging, Dr. Bennett's primary research interest is understanding the neurobiologic pathways linking genetic and environmental risk factors to loss of cognitive and motor function. Dr. Bennett is principal investigator of several studies funded by the National Institute on Aging, including the Rush Alzheimer's Disease Core Center, the Religious Orders Study and the Rush Memory and Aging Project. He also directs the Regional Alzheimer’s Disease Assistance Center for Northern Illinois for the Illinois Department of Public Health. He serves on numerous state, national, and international advisory and editorial boards, and has more than 300 manuscript publications.

Bastiaan R. Bloem, MD, PhD
Professor Bloem is a consultant neurologist at the Department of Neurology, Radboud University Nijmegen Medical Centre, in Nijmegen, the Netherlands. He received his M.D. degree (with honour) at Leiden University Medical Centre in 1993. In 1994, he obtained his PhD degree in Leiden, based on a thesis entitled “Postural reflexes in Parkinson’s disease”. He was trained as a neurologist between 1994 and 2000, also at Leiden University Medical Centre. He received additional training as a movement disorders specialist during fellowships at "The Parkinson's Institute", Sunneyvale, California (with Dr. J.W. Langston), and more recently at the Institute of Neurology, Queen Square, London (with Prof. N.P. Quinn and Prof. J.C. Rothwell). In 2002, he founded and became Medical Director of the Parkinson Centre Nijmegen (ParC), which was recognised from 2005 onwards as centre of excellence for Parkinson’s disease. He is a board member of the Nijmegen Motor Unit (head: Prof. S. Geurts), a fully equipped gait and balance laboratory. In September 2008, he was appointed as Professor in Neurology, with movement disorders as special area of interest. He is currently President of the International Society for Gait and Postural Research, and is on the editorial board for several national and international journals, including the Movement Disorders journal. Since 2009, he is a member of the European Section Executive Committee of the Movement Disorder Society. In 2009, he also joined the board of ZonMw (The Netherlands Organisation for Health Research and Development). Prof. Bloem has published over 250 publications, including more than 195 peer-reviewed papers.

Dr. Bohnen is Associate Professor of Radiology and Neurology at the University of Michigan, Ann Arbor, MI.  He attended medical school in the Netherlands and completed a PhD in neuropsychology.  He completed residency training in neurology (Mayo Clinic, Rochester, MN) and nuclear medicine (University of Michigan, Ann Arbor, MI). He was a fellow in movement disorders at the University of Michigan Medical Center. He holds clinical appointments in Radiology (Division of Nuclear Medicine), Neurology at the University of Michigan and the Ann Arbor VA where he directs the movement disorders clinic. Dr. Bohnen’s research interests include the use of positron emission tomography (PET) in the study of neurodegenerative disorders and normal aging. Current projects include the evaluation of cholinergic, serotonergic and dopaminergic brain activity in patients with Parkinson disease and in community dwelling elderly with motor, cognitive, and mood symptoms. He is the director of the UM functional neuroimaging, cognitive and mobility laboratory where his clinical research has a focus on biomarker development for the diagnosis and treatment monitoring in Parkinson disease. His research is funded by grants from the NIH, the Department of Veterans Affairs, and the Michael J. Fox Foundation.

Dr. Carlson is an Associate Professor in the Department of Mental Health at the Johns Hopkins Bloomberg School of Public Health (SPH) in Baltimore, MD, and Associate Director in the Center on Aging and Health. Dr. Carlson holds joint appointments in the Johns Hopkins School of Public Health Department of Epidemiology and School of Nursing.  Dr. Carlson has examined both environmental and pharmacologic risk modifiers of cognitive aging and has an R01 in the Women’s Health and Aging Study II to characterize trajectories of aging and their downstream effects on higher-order instrumental activities of daily living. She serves as site PI of the Johns Hopkins site of the Ginkgo Evaluation of Memory (GEMS) trial, and a lead Co-Investigator with Dr. Rebok on the P01-funded Baltimore Experience Corps Trial (BECT) to evaluate Program impact on older adults’ cognitive and physical functions. Within this trial, Dr. Carlson has led a nested Brain Health Study (BHS) to evaluate neurocognitive and biologic changes associated with increased activity.

Carl W. Cotman, Ph.D. is a Professor of Neurology, Director of the Alzheimer’s Disease Research Center at the University of California, Irvine, and the Founding Director of the Institute for Brain Aging and Dementia. Dr. Cotman’s main interests are the fields of memory and cognition and the basic mechanisms causing brain dysfunction in aging and the development of Alzheimer’s disease. Recently he has pioneered work on the role of physical activity as a treatment for Alzheimer’s disease. He has published over 700 papers, authored several books and numerous review articles, and is a member of numerous professional associations and committees.

Dr. Cotman received his BA in Chemistry from Wooster College, his MA from Wesleyan University, and Ph.D. in Chemistry from Indiana University. He is the recipient of the 2004 UCI Medal for recognition of his contributions to the field of science, teaching, and community service; and a recipient of the Metropolitan Life Award for Medical Research, and the Allied Signal Award in Aging. In 2005 he was a co-recipient of the Reeve-Irvine Research Award for breakthrough studies in the understanding of the mechanisms underlying adult neuroplasticity, and he received the 2008 Lifetime Achievement Award for research on Alzheimer’s disease by the International Alzheimer’s Conference.

Professor Nir Giladi MD
Department of Neurology
Tel Aviv Sourasky Medical Centre
Sackler School of Medicine
Tel-Aviv University
Tel Aviv, Israel

Dr. Nir Giladi qualified in medicine from Ben-Gurion University, Beer-Sheba, Israel in 1984. After his internship at the Afula Hospital, Afula, Israel, he undertook postgraduate studies in neurology at Sackler Medical School, Tel Aviv University and residency in neurology at Carmel Medical Center, Haifa. Between 1989–1991. Dr Giladi obtained a Fellowship in Movement Disorders from Columbia University, New York, USA. Dr. Giladi has spent time as a visiting professor at Oxford University, Oxford, UK in the year 2000 and in Radboud University Nijmegen, The Netherlands in 2006.
Dr Giladi has been Director of the Movement Disorders Unit at the Tel Aviv Sourasky Medical Centre, Israel, since 1996. He currently holds the position of Professor in Neurology and chairs the Department of Neurology at Tel-Aviv Medical Center.
Dr Giladi has been involved in teaching neurology and neurophysioly to medical students and residents of neurology at Sackler School of Medicine since 1996. He has received numerous medical care and teaching awards and has a decade of experience in conducting clinical trials. Dr. Giladi is currently the Treasurer elect of the International Movement Disorders Society (MDS) and a member of the WFN Study Group on Parkinsonism and other Movement Disorders. Dr. Giladi serves on Editorial Boards of several journals and is a reviewer for many different journals mainly in the field of gait in parkinsonism.
The main research interests of Dr. Giladi are gait disorders in parkinsonism with special emphasis on freezing of gait and mental aspects of gait and falls as well as the genetic basis of Parkinson's disease among Ashkenazi Jews.

Dr. Hallett obtained his M.D. at Harvard University and trained in Neurology at Massachusetts General Hospital.  He had fellowships in Neurophysiology at the National Institutes of Health and at the Institute of Psychiatry in London.  From 1976 to 1984, Dr. Hallett was the Chief of the Clinical Neurophysiology Laboratory at the Brigham and Women's Hospital and Associate Professor of Neurology at Harvard Medical School.  From 1984, he has been at the National Institute of Neurological Disorders and Stroke where he serves as Chief of the Human Motor Control Section and pursues research on the Physiology of Human Movement Disorders and other problems of Motor Control. He also served as Clinical Director of NINDS until July 2000.  He is past President of the American Association of Electrodiagnostic Medicine and the Movement Disorder Society.  He also served as Vice-President of the American Academy of Neurology.  He is an Associate Editor of Brain and Editor in Chief of World Neurology.  Currently he also serves on the editorial boards of Clinical Neurophysiology, Acta Neurologica Scandinavica, Journal of Clinical Neurophysiology, Medical Problems of Performing Artists, Annals of Neurology, The Cerebellum, NeuroTherapeutics, and European Neurology.  The main work of his group focuses on the physiology and pathophysiology of movement. Dr. Hallett’s interests in Motor Control are wide-ranging, and include brain plasticity and its relevance to neurological disorders and the pathophysiology of dystonia, parkinsonism, and myoclonus.  Recently he has become interested in disorders of volition, including tic and psychogenic movement disorders. 

Janet Hamburg, MA, CMA, RSMT, is a Registered Somatic Movement Therapist and a Certified Laban Movement Analyst. She is an Associate of the Gerontology Center and a professor of dance at the University of Kansas. She also is the Director of Senior Wellness and Exercise for the Center for Movement Education and Research in Los Angeles and a Senior Research Associate for the Laban/Bartenieff Institute of Movement Studies in New York City. Hamburg’s research interests include coordination problems in children and adults, movement efficiency for athletes, and therapeutic exercise for older adults and people with Parkinson’s disease. Her work with athletes has been featured on NBC national television and the U.S. Information Agency’s international program Science World. Her research on Parkinson's disease resulted in an award-winning exercise DVD/video, Motivating Moves for People with Parkinson's, originally co-produced by the Parkinson's Disease Foundation. Her research on gait, balance and flexibility in the older adult population has been published in refereed journals. Hamburg has presented her research at national and international conferences including those of the American Society on Aging and the National Council on the Aging, the World Parkinson Congress and the International Congress of the Movement Disorder Society.

Prof. Jeffrey M. Hausdorff is the Director of the Laboratory for the Analysis of Gait and Neurodynamics at Tel-Aviv Sourasky Medical Center, Associate Professor at the Sackler Faculty of Medicine, and Lecturer in Medicine at Harvard Medical School. Prof. Hausdorff completed studies in biomechanics and biomedical engineering at The Cooper Union (BSE), the Massachusetts Institute of Technology (MSME), and Boston University (PhD). For his PhD research, he developed a novel method for studying the step-to-step changes in human walking using a "wearable" computer and discovered the presence of fractal-like behavior in the apparently random fluctuations in gait. Prof. Hausdorff also completed post-doctoral training in the Division on Aging at Harvard Medical School.  

Prof. Hausdorff's lab investigates neurodynamics and the study of postural control and gait, fractal physiology, movement disorders, and brain function. A special focus is placed on falls in older adults, in patients with Parkinson's disease, and in other populations who have an exacerbated risk of falling, and on the interactions between cognitive function and gait.  Current work includes the development of wearable-computing based methods for assessing of balance, gait and fall risk in the clinic and at-home; research into the patho-physiologic mechanisms underlying specific gait alterations and the contribution of mental function to these changes; and the development of novel therapeutic approaches to reducing fall risk such as those based on virtual reality, pharmacologic interventions and bio-feedback.


Roee Holtzer, PhD.
Dr. Holtzer is an assistant professor at Ferkauf Graduate School of Psychology and the Department of Neurology at Albert Einstein College of Medicine of Yeshiva University.  He is also the director of the Minor in Clinical Neuropsychology.  Dr. Holtzer earned his doctorate degree in clinical psychology with a secondary emphasis on neuropsychology at the State University of New York at Binghamton. He completed his internship training in Clinical Psychology at the Rusk Institute of New York University.  He also completed a T-32 Post-doctoral fellowship in Neuropsychology and Cognition in Aging and dementia at the Cognitive Neuroscience Division of the Sergievsky Center of Columbia University Medical Center. He is licensed as a psychologist in New York State.

Dr. Holtzer is a recipient of the Beeson award from the National Institute on Aging.  He studies higher order cognitive functions such as attention, memory, and executive control in normal and clinical populations. Further, he is interested in studying the utility of cognitive functions as markers of disease progression or remission and as predictors of outcomes that are of major clinical and public health interest. His current funded research uses a multi-level theory-driven method integrating clinical, cognitive neuroscience, and genetic approaches to identify predictors of gait and falls in aging.  The long-term goal of this translational research is to identify specific modifiable mechanisms pertinent to developing more efficient risk assessment and intervention programs of cognitive and motor decline in aging.

Fay Horak, P.T., Ph.D., is a Research Professor in the Dept of Neurology and Adjunct Professor of Physiology and of Biomedical Engineering at OHSU.

As a physical therapist and motor control neurophysiologist, Dr. Horak studies neural control of balance and gait in neurological patients and how to translate that knowledge into improved rehabilitation of balance disorders.  Her current research focuses on quantifying balance and gait disorders associated with Parkinson’s disease and developing a unique agility exercise program to prevent mobility disability.  She has recently developed a novel approach to longitudinal measurement of balance and gait using unobtrusive ambulatory sensors that will be important for future clinical trials of potentially neuroprotective medications.

Dr. Horak’s laboratory is considered the best in the world to study how the brain controls balance.  She is internationally renowned with more than 200 publications and numerous awards.  For example, she has been honored by the NIH with a rare MERIT award based on 30 years of continuous funding from the National Institutes on Aging and by the American Physical Therapy Association who presented her with a prestigious, uncommon national research award. 
Dr. Horak received her Ph.D. in neuroscience from the University of Washington in 1982, MS from the U of Minnesota in 1977 and completed her degree in physical therapy at the University of Wisconsin in 1973.  Her work at a physical therapist led to her involvement in research and eventually to pursue a Ph.D.; her interest in researching balance and gait has been a life-long pursuit.
Dr. Horak’s recruitment is the result of private philanthropy.  With the funds provided by the Benaroya Foundation and numerous donors to the Parkinson Center of Oregon, the Dept. of Neurology was able to recruit Dr. Horak and her research team.  Her Balance Disorders laboratory is sophisticated and technological; her work quantifying balance and gait will allow clinicians to more accurately and quickly assess the benefits of treatment.  Dr. Horak’s research is highly collaborative and she has worked with scientists around the globe.  At OHSU, Dr. Horak has worked with Jay Nutt, M.D. to secure several grants from the Kinetics Foundation.  Dr. Horak is also working with dyskinesia, fibromyalgia, vestibular and multiple sclerosis experts at OHSU and collaborators in bioengineering at Portland State University.


Jeffrey Kaye, MD

Jeffrey Kaye is Professor of Neurology and Biomedical Engineering at Oregon Health and Science University (OHSU). He is Director of the Oregon Center for Aging and Technology (ORCATECH) and the Layton Aging and Alzheimer’s Disease Center, both at OHSU in Portland, Oregon. He also directs the Geriatric Neurology program at the Portland Veteran’s Affairs Medical Center. His research has focused over the past two decades on the question of why some individuals remain protected from frailty and dementia at advanced ages while others succumb at much earlier times. This work has relied on a number of biomarker techniques ranging across several fields of inquiry including neuroimaging, genetics and continuous activity monitoring. A centerpiece of his studies has been the Oregon Brain Aging Study, established in 1989. He currently leads a longitudinal NIH study, Intelligent Systems for Assessing Aging Changes (ISAAC)” using ubiquitous, unobtrusive technologies for automated assessment of seniors in their homes to detect changes signaling imminent decline of function.

Dr. Kaye has received the Charles Dolan Hatfield Research Award for his work. He is listed in Best Doctors in America. He serves on many national and international panels and review boards in the field of geriatrics, neurology and technology including as a commissioner for the Center for Aging Services and Technology (CAST), chair of the Working Group on Technology for the Alzheimer’s Association and on the Advisory Council of the International Society to Advance Alzheimer Research and Treatment (ISTAART). He is an author on over 200 scientific publications and holds several major grant awards from federal agencies, national foundations and industrial sponsors.

Arthur Kramer is Swanlund Chair and Professor of Psychology and Neuroscience at the University of Illinois.   He received his Ph.D. in Cognitive/Experimental Psychology from the University of Illinois in 1984. Professor Kramer’s research projects include topics in Cognitive Psychology, Cognitive Neuroscience, Aging, and Human Factors.  A major focus of his labs recent research is the understanding and enhancement of cognitive and neural plasticity across the lifespan.  He is the Director of the Biomedical Imaging Center at the University of Illinois and Zukunftskolleg Senior Fellow at the University of Konstanz. Professor Kramer served as an Associate Editor of Perception and Psychophysics and is currently a member of six editorial boards. He is a fellow of the American Psychological Association, American Psychological Society, a member of the executive committee of the International Society of Attention and Performance, a member of the National Academy of Sciences Committee on Human Systems Integration, and a recent recipient of a NIH Ten Year MERIT Award. Professor Kramer’s research has been featured in a long list of print, radio and electronic media including the New York Times, Wall Street Journal, Washington Post, Chicago Tribune, CBS Evening News, Today Show, NPR and Saturday Night Live.


Professor Lamb qualified in 1986 from Salford School of Physiotherapy, and has worked in the UK, Australia, New Zealand and the United States. She was awarded an MSc in Rehabilitation with Distinction from Southampton University in 1991, and a DPhil from Oxford University in 1998. She was awarded a Harkness Fellowship in 1995 to study fall and disability prevention in older people in the United States of America. She is a member of the Chartered Society of Physiotherapy and a Fellow of the Royal Statistical Society. Her current position at the University of Warwick is that of Director of the Clinical Trials Unit and Professor of Rehabilitation. In addition she holds the Kadoorie Professorship of Trauma Rehabilitation at the University of Oxford. She was awarded a National Institute of Health Research Senior Investigator Award in 2008 in recognition of outstanding contributions to patient centred research in the National Health Service. Recently Professor Lamb has also been appointed Chair of the HTA Clinical Evaluation and Trials Board. Professor Lamb's research interests span clinical trials methodology, with particular application in gerontology, musculo-skeletal sciences, physiotherapy and more latterly, critical and emergency healthcare.

Anthony E. Lang, MD, FRCPC
Dr. Lang trained in Internal Medicine and Neurology at the University of Toronto.  He then undertook postgraduate training in Movement Disorders at Kings College Hospital and the Institute of Psychiatry in London, England under the late Professor David Marsden.  He returned to Toronto in 1982 and shortly thereafter initiated the Movement Disorders Clinic at the Toronto Western Hospital which has developed into the largest Movement Disorders Clinic in Canada and one of the most reputable units in the world for the investigation, assessment and treatment of patients with movement disorders.  Dr. Lang’s research has included clinical studies of poorly recognized neurological disorders, clinical trials of new therapeutic modalities and collaborative basic and clinical studies involving molecular biology, neurophysiology, neuropsychology and imaging.  He has published over 390 peer reviewed papers, many in important medical journals including the New England Journal of Medicine, the Lancet, Nature Medicine, the Annals of Neurology, Brain, etc.  Dr. Lang was one of the founding members and initial Executive Committee members of the Parkinson Study Group (PSG).  He served on the Steering Committee of the first large scale neuroprotective therapies study in Parkinson’s disease (the DATATOP trial) carried out by the PSG, and funded by NIH and has served on many other Steering Committees for PSG studies since then. Dr. Lang has served on the Movement Disorders Society (MDS) International Executive Committee and as Treasurer from 1988-1992 and Secretary from 1996-1998.  He served as the MDS President from January 2007- June 2009 and is the current Past President.   He served as CoEditor-in-Chief of the international journal Movement Disorders between 1996 and 2003 inclusive.  Dr. Lang is Professor and Director of the Division of Neurology at the University of Toronto, Director of the Movement Disorders Center at the Toronto Western Hospital, the Jack Clark Chair for Parkinson’s Disease Research at the University of Toronto and was the recipient of the 2005 Research Award for the Department of Medicine at the University of Toronto and the Donald Calne Lectureship from Parkinson Society Canada in 2008. Dr. Lang is a Fellow of the American Academy of Neurology and was the recipient of the AAN Movement Disorders Research Award in 2004. 

Lillemor Lundin-Olsson, PT, PhD, is an Associate Professor at the Dept of Community Medicine and Rehabilitation at Umea University in Sweden. Her research theme is identification of fall risk factors and fall prevention strategies in old age. In longitudinal studies she has evaluated field measurements of gait and balance as predisposing fall risk factors both among community living independent and frail older people, with emphasis on people with dementia. A special focus is placed on the interactions between gait and cognitive function. This includes studies of gait pattern changes by use of an electronic gait mat and a dual-task paradigm and in virtual environments with unexpected events. Dr Lundin-Olsson has contributed to a shift in focus of gait assessment from plain walking to dual-task walking. In randomized controlled trials she has evaluated effects of fall prevention programs among frail older people in residential care settings. She has had an important role in the development of national fall prevention guidelines and she was a member of the Prevention of Falls Network Europe (PROFANE).  

Professor Stephen Lord is a Senior Principal Research Fellow at the Prince of Wales Medical Research Institute. He has worked in the areas of applied neurology, instability, falls and fractures in older people and is acknowledged as a leading international researcher in his field. Professor Lord’s research on falls has followed two main themes: the identification of risk factors and the evaluation of prevention strategies. His studies have involved large prospective population studies and randomised controlled trials for assessing the effectiveness of exercise programs in improving strength, balance and co-ordination and preventing falls in community dwelling people and residents of aged care facilities. He has published over 200 scientific papers and a comprehensive book on Falls in Older people. Professor Lord has placed a major emphasis on translation of research findings into policy and practice and has contributed to best Practice Falls Prevention Guidelines and policy formulation. His methodology and approach to falls-risk assessment has been adopted by many researchers and clinicians across the world.

Richard F. Macko, M.D.
Director of the VA Maryland Exercise & Robotics Center of Excellence (MERCE). Professor, Department of Neurology and Medicine, Division of Gerontology, Physical Therapy and Rehabilitation Science. He is the Academic Director of the Rehabilitation Medicine Division at University of Maryland School of Medicine and the Associate Director of Research for the Baltimore VA Geriatrics Research Education and Clinical Center, and VA Stroke Research Enhancement Award Program. Dr. Macko coordinates the overall management and scientific directions of MERCE in collaborations with the MERCE Internal Advisory Committee and other Center faculty. Dr. Macko’s principal research areas are development of task-oriented exercise for Veteran’s disabled by stroke and other chronic neurological disability and disease conditions with emphasis on those associated with advancing age and the integration of robotics assisted rehabilitation with exercise. His interests include expanding exercise and robotics therapies to improve function and health to individuals with a diversity of other disability conditions. He plays a central role in mentoring clinician-scientists and PhD Fellows in the design and conduct of disability and disease specific exercise rehabilitation programs. His programmatic contributions also include facilitating inter-institutional collaborations and clinical translation of exercise and robotics therapies out to the community. 

Jane Mahoney, MD 
Dr. Mahoney is Associate Professor of Geriatrics in the Department of Medicine, at the University of Wisconsin School of Medicine and Public Health.  Through funding from the National Institute of Aging, American Physical Therapy Foundation, Centers for Disease Control and Prevention, and State of Wisconsin Department of Health and Family Services, her research has focused on risk factors for falls after hospitalization, clinical trials of community-based multifactorial interventions to decrease falls, and dissemination research on falls prevention.  Currently, she is working with State of Wisconsin Department of Health and Family Services to disseminate two evidence-based falls prevention programs across Wisconsin. Additionally, with funding from the Centers for Disease Control and Prevention she is conducting dissemination research in falls prevention, examining “Stepping On” implementation in Wisconsin communities.   

Rolf Moe-Nilssen , PhD, PT, Professor, Section for Physiotherapy Science, University of Bergen, Norway, was a member of the European Commission research network Prevention of Falls Network Europe (PROFANE), and has been keynote and invited speaker at international conferences on motor control, biomechanics, gait analysis, and geriatrics. He has a research interest in balance control during walking, and has developed ambulatory methodology based upon body fixed kinematic sensors for assessing balance during standing and walking. An advantage of wearable technology over traditional laboratory equipment is its portability which allows a variety of environmental conditions including walking on uneven ground. Professor Moe-Nilssen has contributed to a shift in focus from the movements of the legs to also include the role of the trunk in balance control during walking. His recent and ongoing research on locomotor control in clinical populations include studies on variability in gait as noise, impairment and adaptability.    

Alice Nieuwboer is working as a professor at the Faculty of Kinesiology and Rehabilitation Sciences of the Katholieke Universiteit Leuven in Belgium. She is teaching both undergraduate and postgraduate physiotherapy students in specialised topics in neurological rehabilitation and evidence-based physiotherapy. Within the faculty she is program director of undergraduate and postgraduate courses in Rehabilitation Science. She was principal investigator of the EU-funded RESCUE-project (2002-2005) on cueing in Parkinson’s disease and has published widely in the field of neurological rehabilitation. Her present research efforts are dedicated to gait rehabilitation, freezing of gait, falling, mechanisms of cueing and upper limb coordination.


Dr. John Nutt
Co-Founder and Director of the OHSU Parkinson Center of Oregon (PCO) and Movement Disorders Program and Co-Director of the Portland VAMC Parkinson's Disease Research, Education and Clinical Center.
Dr. Nutt received his medical degree and a masters in Pharmacology from Baylor College of Medicine. Clinical fellowships were completed at the Addiction Research Institute in Lexington, Kentucky (1971-73) and NIH-NINDS Experimental Therapeutics Branch (1975-78).
Dr. Nutt joined the OHSU movement disorders faculty in 1978 and is currently a Professor of Neurology. He is an expert clinician, scientist and teacher.
Dr. Nutt has gained international recognition for his innovative research in movement disorders and is widely used as a scientific consultant in the development of many new therapeutic agents for Parkinson's disease. He is widely recognized for his work on the pharmacokinetics of levodopa which has provided significant clinical and scientific insight on this important therapy for PD. His background in pharmacology has made him a world leader in testing many novel therapeutics for Parkinson's disease as well as new neuroprotective and neurorestorative therapies. He has also become a world leader and international expert in understanding the gait and balance problems of PD and ways to better manage these problems.
Dr. Nutt is an expert clinician for all movement disorders.

Mark S. Redfern, Ph.D is a William Kepler Whiteford Professor of Bioengineering at the University of Pittsburgh.   He has appointments in the Departments of Bioengineering, Otolaryngology, and Physical Therapy.  He received his Ph.D. in Bioengineering from the University of Michigan.  Dr. Redfern’s research is focused in two areas:  human postural control and ergonomics.  The major goal of the postural control research is the prevention of falling injuries by investigating the factors that influence balance in older adults and patients with balance disorders. OF particular interest is the impact of aging and vestibular function on sensory integration processes.  The ergonomic research focus has been in the area of fall prevention and reducing injuries in the workplace through ergonomic redesign.  

Dr. Stephen Reich is professor of Neurology at the University of Maryland and co-director of the Maryland Parkinson’s Disease and Movement Disorders Center. He is a graduate of Tulane School of Medicine and completed a neurology residency at Case Western in Cleveland followed by a fellowship in movement disorders at Johns Hopkins under Dr. Mahlon DeLong. He then served on the faculty at Johns Hopkins until moving to the University of Maryland in 2002. Dr. Reich is a member of the editorial board of Movement Disorders and serves on the education committee of the Movement Disorders Society. He is the editor of Movement Disorders: 100 Instructive Cases (Informa Press).

Stephen Robinovitch is an Associate Professor in the Department of Biomedical Physiology and Kinesiology, and in the School of Engineering Science, at Simon Fraser University, Canada. He received his B.App.Sc. from the University of British Columbia in 1988, and his Ph.D. in Medical Engineering from Harvard/MIT in 1995. Before commencing his position at SFU in 2000, he was an Assistant Professor at the University of California, San Francisco. He currently holds a Canada Research Chair award, and is the previous recipient of a New Investigator Award from the CIHR. Dr. Robinovitch’s research focuses on the cause and prevention of falls and fall-related injuries, especially in older adults. His group is one of the few to have examined the descent and impact stages of falls, through a combination of experiments conducted in his unique “falling laboratory” (involving motion capture, electromyography, and impact force measurement) and mathematical modeling. In 2007, he served as Principal Investigator for the CIHR-funded International Hip Protector Research Group, which recently published recommended guidelines for biomechanical testing and clinical trials of hip protectors. For the past two years, he has led a study to record, for the first time, “real life” falls experienced by older adults residing the long-term care environment, through a network of digital video cameras. To date, his team has acquired and analyzed over 200 falls in older adults. These data challenge previous evidence (based on witness reports or self-reports) of the cause and circumstances of falls, and provide a unique opportunity for examining how fall mechanisms associate with physical and cognitive function.

Dr. Caterina Rosano is a physician and geriatric neuroepidemiologist. She is currently the PI of a brain MRI study of participants of the Health Aging and Body Composition Study. Dr. Rosano is developing a model to identify the determinants of cognitive and physical aging among community-dwelling older adults. Dr. Rosano has applied multimodal MRI measures of brain structural and functional integrity in longitudinal epidemiological studies of aging, including the Cardiovascular Health Study, the Gingko Evaluation Memory, the AGES-Reykjavik and the LIFEp study. By understanding the relationship between brain and physical function, Dr. Rosano hopes to identify predictors of successful aging.
Dr. Rosano has obtained an MD from the School of Medicine, Palermo, Italy, in 1995 and an MPH at the U. of Pittsburgh in 2003. Prior to her training in neuroepidemiology, she has been a postdoctoral fellow at the Jackson Memorial Hospital in Miami, where she measured the neuroregenerative potential of the gray and white matter of the central nervous system.  She subsequently joined the Neurobehavioral Research unit at the University of Pittsburgh (1999- 2001) and used brain fMRI to investigate age-related changes in brain performance and sensorimotor integration. From 2001-2004, Dr. Rosano was a selected NIA Fellow in the Department of Epidemiology at the University of Pittsburgh while studying the epidemiology of age-related brain structural and functional impairment.

Dr. Glenn Smith is a board-certified clinical neuropsychologist who specializes in cognitive aging and dementia.  He is a professor of psychology at the Mayo Clinic College of Medicine, a consultant in the Department of Psychiatry and Psychology, and principal investigator of the Mayo Alzheimer's Disease Research Center Education Core.  He is director of the post-doctoral research education programs within Mayo’s Clinical and Translation Science Activities. 
Dr. Smith received his PhD in Clinical Psychology from the University of Nebraska, completed his internship at the Neuropsychiatric Institute at UCLA and did a post-doctoral fellowship in Clinical Neuropsychology at the Mayo Clinic. He has authored or co-authored over 150 original articles.  He is the clinical director of the Alzheimer’s Disease resource on  
Dr. Smith’s research interests include early diagnosis of dementia, dementia outcomes, depression and behavioral disturbance in the dementias, and memory enhancing approaches in normal aging and mild cognitive impairment.
He is past president of the American Board of Clinical Neuropsychology and the Division of Clinical Neuropsychology of the American Psychological Association.  

Dr. Stephanie Studenski, MD, MPH
Dr. Stephanie Studenski is a geriatrician and rheumatologist whose practice, teaching and research focus on mobility, balance disorders and falls in older adults.   Through her research, she strives to understand balance and mobility problems that occur with obvious conditions such as stroke, as well as those of more insidious onset that may be related to subclinical losses in multiple organ systems.  She has been continuously funded by NIH, VA and other sources for over 20 years and has published over 150 articles and book chapters. She has been active in AGS as Chair of the Research Committee and member of the Board of Directors. She has served as Chair of three NIH Study sections. She is a member of the Editorial Boards of the Journal of the American Geriatrics Society, the Journal of Geriatric Pharmacotherapy , the Journal of Aging, Health and Nutrition and is an Associate Editor for the Journal of Gerontology Medical Sciences   Dr Studenski is currently the principal investigator of the Claude D Pepper Older Americans Independence Center at the University of Pittsburgh.  She is also PI or co-PI of grants related to the prognostic value of gait speed in older adults, the role of dopamine depletion in falls and balance disorders, a recently completed program project on cancer and aging, and several training grants. 

Professor Chris Todd, Professor of Primary Care and Community Health

Director of Research School of Nursing, Midwifery, and Social Work, University of Manchester.  Director Prevention of Falls Network Europe (ProFaNE)

Professor Chris Todd read Psychology at the University of Durham obtaining BA, MA and PhD. As a post-doc he worked at the University of Ulster before moving to the Institute of Public Health, University of Cambridge where he became Director of the Health Services Research Group and a Fellow of Wolfson College.  In 2001 he was appointed to his Chair at The University of Manchester and Director of Research for the School recognised as the top research school in the UK RAE2008 government review.

He has more than 25 years experience of research. He has two parallel research interests (i) supportive and palliative care, and (ii) fall prevention in old age. He has held grants from UK Department of Health, NHS, NCRI, MRC, European Commission and research charities including CRUK, BCC and Dimbleby Cancer Care. He reviews for a wide range of research committees and journals, and is currently a member of MRC College of Experts. He is author /co-author of more than 150 publications, including the WHO reports on falls prevention. He is Director of the Prevention of Falls Network Europe (ProFaNE).

Dr. Ergun Uc is an Associate Professor at the Department of Neurology, Carver College of Medicine, University of Iowa, with a joint appointment at the Veterans Affairs Medical Center of Iowa City. Dr. Uc received his M.D. degree (1988) from University of Istanbul, Turkey, and has completed his Neurology Residency (1994) and Movement Disorders Fellowship (1996) at the University of Iowa. He is the director of the movement disorders fellowship at the University of Iowa and of the movement disorders clinic at the VA Medical Center. He participates in clinical trials by Parkinson and Huntington Study Groups. Dr. Uc’s research focuses on cognitive aspects of Parkinson’s disease and he is the co-chair of the Cognition/Behavior Workgroup of the Parkinson Study Group. He serves as an ad hoc reviewer for multiple scientific journals and a grant reviewer for different institutions nationally and internationally. In addition to past research support from private foundations such as American Parkinson Disease Association and Parkinson’s Disease Foundation, Dr. Uc is the principal investigator of several federally funded studies including prediction of driver safety in Parkinson’s disease (National Institutes of Health-R01), driver rehabilitation in PD (VA-Merit Review), and effect of aerobic exercise on function and cognition in PD (VA-Merit Review).

Joe Verghese, MBBS, MS
Dr. Joe Verghese graduated from St. Johns Medical College, Bangalore, India in 1989. He then completed postgraduate training in Internal Medicine and Neurology in United Kingdom. He completed his Neurology residency at the Albert Einstein College of Medicine, Bronx, NY in 1998.  He did fellowship training in Neurophysiology as well as Aging & Dementia in 1999 at the same institution. He received a Master of Science degree in Clinical Research Methods with Distinction in 2001. Dr Verghese is board-Certified in Neurology.

Dr. Verghese is Associate Professor and Director of the Division of Cognitive & Motor Aging in the Department of Neurology at the Albert Einstein College of Medicine. He is the Louis and Gertrude Feil Faculty Scholar in Neurology. He is also Clinical Director of the Einstein Aging Study, a NIH funded longitudinal aging study.

Dr. Verghese is a recipient of the Beeson award from the National Institute on Aging and the Outstanding Scientific Achievement for Clinical Investigation Award from the American Geriatrics Society. His research interest is the effects of disease and aging on mobility and cognition in older adults, and he has had several peer-reviewed publications and federally funded research grants in this area. His current projects include studying the influence of cognitively stimulating activities on reducing risk of dementia, global health studies in dementia, and the role of divided attention tasks such as walking while talking in predicting outcomes such as disability and cognitive decline.